covid 19 News and Research

RSS

COVID-19 vaccination provides higher concentrations of antibodies to babies and pregnant people

Pregnant people who received one of the mRNA COVID-19 vaccines had 10-fold higher antibody concentrations than those who were naturally infected with SARS-CoV-2, a finding that was also observed in their babies, according to a new study by researchers at Children's Hospital of Philadelphia and the University of Pennsylvania.

9 Nov 2022

Study highlights major disparities in geographical access to COVID-19 "Test to Treat" sites

A new study from investigators at Brigham and Women's Hospital, a founding member of Mass General Brigham, the University of Virginia School of Medicine, and the University of Pittsburgh, finds that COVID-19 "Test to Treat" sites -; clinical centers launched based on a federal initiative to provide free testing, diagnosis, and immediate access to COVID-19 antiviral treatment with Paxlovid -; may not be accessible to those who need it most.

9 Nov 2022

Major life stressors may worsen long COVID symptoms

The death of a loved one, financial or food insecurity, or a newly developed disability were some of the strongest predictors of whether a patient hospitalized for COVID-19 would experience symptoms of long COVID a year later, a new study finds.

9 Nov 2022

Cloned SIA licenses led to unlicensed people working as hospital security during pandemic

Friday's sentence follows Ojugbele's guilty plea to fraud on Thursday 29 September. This prosecution follows an investigation by the Security Industry Authority (SIA). A routine inspection by the in-house security manager of a Manchester city center public hospital in 2020 identified multiple cases of cloned SIA licenses.

9 Nov 2022

Long-term effects of SARS-CoV-2 on the brain

More profoundly than previously believed, the virus that causes COVID-19, SARS-CoV-2, can impact the brain for months after infection.

9 Nov 2022

MHRA grants approval for second Pfizer/Biontech bivalent Covid-19 booster vaccine

Approval has today been granted by the Medicines and Healthcare products Regulatory Agency (MHRA) for a Pfizer/BioNTech 'bivalent' Covid vaccine that targets both the Original strain of SARS-CoV-2 and the Omicron BA.4 and BA.5 sub-variants.

9 Nov 2022

What is the role of adenoviruses in human health?

With advances in molecular biology informing recent developments in vaccinology, gene therapy, and other fields of medicine, human adenoviruses (HAdVs) have been of primary importance in medical research. A recent review looks at the promises of HAdVs, their potential dangers, and future challenges.

9 Nov 2022

People with long covid face barriers to government disability benefits

When Josephine Cabrera Taveras was infected with covid-19 in spring 2020, she didn't anticipate that the virus would knock her out of work for two years and put her family at risk for eviction.

9 Nov 2022

Mortality rate and risk among hospitalized COVID-19 patients during different surges of the pandemic

Researchers assessed the mortality rates associated with SARS-CoV-2 Alpha (B.1.1.7) and Delta (B.1.617.2) variant infections.

9 Nov 2022

Does fenofibrate improve clinical outcomes in patients with COVID-19?

Researchers assessed the effect of fenofibrate on acute COVID-19.

9 Nov 2022

The direct and indirect effects of COVID-19 on people with type 1 and type 2 diabetes

A recent study published in The Lancet Diabetes & Endocrinology discussed the impact of COVID-19 on individuals with diabetes.

9 Nov 2022

Study indicates widespread SARS-CoV-2 exposure in wildlife

In a recent study posed to the bioRxiv* preprint server, researchers at Virginia Tech University investigated wildlife exposure to SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2).

8 Nov 2022

Outcomes from an Australian COVID-19 virtual ward during Omicron wave

In a recent study posted to the medRxiv* preprint server, researchers in Australia characterized hospitalization volumes, patient epidemiological and clinical outcome data of patients admitted to virtual wards during the predominance of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant of concern (VOC) BA.1 sub-VOC and the Omicron BA.2 sub-VOC.

8 Nov 2022

Study helps understand the basis of sex differences in SARS-CoV-2 infection

Significant immunological differences between young men and women were shown to mediate sex differences in the responses to the virus that causes COVID-19, according to a collaborative study of nearly 3,000 young, healthy members of the U.S. Marine Corps.

8 Nov 2022

Research estimates the changing burden of COVID-19 in Austin, Texas

In a recent study posted to the medRxiv* preprint server, researchers estimated the time-varying burden of coronavirus disease 2019 (COVID-19) by ZIP codes and individual age in Austin, Texas.

8 Nov 2022

Higher dose of pneumococcal vaccine improves antibody response in patients receiving rituximab for ANCA-associated vasculitis

New research presented this week at ACR Convergence 2022, the American College of Rheumatology's annual meeting, showed that a higher dose of pneumococcal vaccine safely and effectively improved antibody response in patients receiving rituximab for ANCA-associated vasculitis.

8 Nov 2022

Pediatric deaths due to COVID-19 remain very low, study shows

A new study conducted in England shows that the risk of death due to COVID-19 remains very low for children and young people, and most deaths occur in those with underlying health conditions.

8 Nov 2022

Researchers identify 55 broadly reactive monoclonal antibodies to betacoronaviruses

In a recent study published in the journal Cell Host & Microbe, researchers pursued novel approaches that could help find monoclonal antibodies (mAbs) broadly targeting coronaviruses (CoVs), especially genera beta CoVs.

8 Nov 2022

Skipping methotrexate for one week after flu vaccine provides the same seroprotection as a two-week hold in RA patients

New research presented this week at ACR Convergence 2022, the American College of Rheumatology's annual meeting, showed that discontinuing methotrexate for one week after seasonal influenza vaccination provided the same seroprotection as a two-week discontinuation period in patients with rheumatoid arthritis.

8 Nov 2022

Study identifies novel inhibitors against SARS-CoV-2 main protease

In a recent study posted to the bioRxiv* server, researchers at the University of Arizona screened ~11 million severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) main protease (MPro)-inhibiting small compounds in the ZINC15 database using a structure-based in-silico screening method.

8 Nov 2022

covid 19 News and Research

COVID-19 vaccination provides higher concentrations of antibodies to babies and pregnant people

Study highlights major disparities in geographical access to COVID-19 "Test to Treat" sites

Major life stressors may worsen long COVID symptoms

Cloned SIA licenses led to unlicensed people working as hospital security during pandemic

Long-term effects of SARS-CoV-2 on the brain

MHRA grants approval for second Pfizer/Biontech bivalent Covid-19 booster vaccine

What is the role of adenoviruses in human health?

People with long covid face barriers to government disability benefits

Mortality rate and risk among hospitalized COVID-19 patients during different surges of the pandemic

Does fenofibrate improve clinical outcomes in patients with COVID-19?

The direct and indirect effects of COVID-19 on people with type 1 and type 2 diabetes

Study indicates widespread SARS-CoV-2 exposure in wildlife

Outcomes from an Australian COVID-19 virtual ward during Omicron wave

Study helps understand the basis of sex differences in SARS-CoV-2 infection

Research estimates the changing burden of COVID-19 in Austin, Texas

Higher dose of pneumococcal vaccine improves antibody response in patients receiving rituximab for ANCA-associated vasculitis

Pediatric deaths due to COVID-19 remain very low, study shows

Researchers identify 55 broadly reactive monoclonal antibodies to betacoronaviruses

Skipping methotrexate for one week after flu vaccine provides the same seroprotection as a two-week hold in RA patients

Study identifies novel inhibitors against SARS-CoV-2 main protease

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News